VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SURG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SURGSurgePays, Inc.
$0.41$9M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. SURG
  4. Financial Ratios

SurgePays, Inc. (SURG) Financial Ratios

Latest Ratios: P/E Ratio -0.2x · EV/EBITDA N/A · ROE N/A. (2006–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

SURG Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$9M$34M$34M$96M$81M$9M$13M$29M$31M——
Enterprise Value$21M$45M$27M$87M$82M$10M$20M$37M$32M——
P/E Ratio →-0.23——4.67———————
P/S Ratio0.150.590.560.700.670.170.231.122.03——
P/B Ratio——2.233.3915.892.49—————
P/FCF———9.62858.73——————
P/OCF———9.36102.50——————

P/E links to full P/E history page with 30-year chart

SURG EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.800.440.630.680.200.361.442.09——
EV / EBITDA———4.3650.78——————
EV / EBIT———4.5958.62——————
EV / FCF———8.70870.09——————

SURG Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin-18.6%-18.6%-23.5%26.0%11.1%12.1%4.5%12.1%43.8%48.7%29.4%
Operating Margin-59.9%-59.9%-68.6%13.8%0.5%-11.7%-18.6%-30.2%-10.1%-144.7%-94.2%
Net Profit Margin-63.3%-63.3%-75.1%15.0%-0.6%-26.5%-19.7%-32.8%-10.1%-138.5%-139.5%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE——-209.5%123.0%-15.7%-381.0%———-326.2%—
ROA-222.0%-222.0%-138.8%54.3%-2.5%-100.9%-123.9%-120.1%-42.6%-72.0%-184.6%
ROIC-1135.0%-1135.0%-229.7%111.3%8.5%-738.6%—-509.7%-731.0%-198.8%-399.4%
ROCE-828.3%-828.3%-177.3%94.9%6.3%-786.7%—-698.4%—-313.9%—

SURG Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity——0.300.191.582.16———1.80—
Debt / EBITDA———0.275.00——————
Net Debt / Equity——-0.47-0.320.210.39———1.45—
Net Debt / EBITDA———-0.460.66——————
Debt / FCF———-0.9211.36——————
Interest Coverage-17.03-17.03-76.7131.840.72-0.80-1.71-36.21-9.39-65.08-1.77

SURG Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.380.382.952.631.171.390.080.510.640.130.19
Quick Ratio0.370.372.661.910.700.950.0724472.990.64-0.08-0.01
Cash Ratio0.100.101.951.150.300.630.040.050.090.090.02
Asset Turnover—6.692.543.273.572.627.432.583.730.451.40
Inventory Turnover198.93198.9342.2211.229.6610.30291.28—789.011.412.88
Days Sales Outstanding—25.9217.9925.3827.7223.232.6444.4129.8714.3014.00

SURG Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———21.4%———————
FCF Yield———10.4%0.1%——————
Buyback Yield0.0%0.0%1.9%0.0%0.0%0.0%4.0%0.0%0.0%——
Total Shareholder Yield0.0%0.0%1.9%0.0%0.0%0.0%4.0%0.0%0.0%——
Shares Outstanding—$20M$19M$15M$12M$4M$2M$2M$2M$2M$895926

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and Solvency Risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Distressed Valuation Reflects Operational Uncertainty

Based on reported financial data, SurgePays trades at a P/S multiple of 0.14, which, according to recent market filings, suggests that investors are heavily discounting the company's future revenue potential due to the persistent absence of positive earnings and the expiration of critical federal subsidy programs.

The lack of meaningful P/E or EV/EBITDA multiples underscores the market's view of the company as a distressed asset rather than a growth-oriented software firm. This valuation compression appears to be a rational response to the company's inability to demonstrate a path toward sustainable profitability or positive cash flow generation.

Capital Efficiency Decaying Into Deficit

As reported in financial statements, the company's ROIC has plummeted from a positive 6.9% in 2024Q1 to a deeply negative -116.9% by 2025Q3, indicating that capital allocation has failed to generate value and is instead eroding the firm's underlying equity base at an accelerating rate.

The consistent decline in return metrics suggests that management's strategy of aggressive expansion into niche retail markets has not achieved the necessary scale to offset high operating costs. Investors should monitor whether the current capital structure can support further operations without significant dilution or additional debt financing.

Working Capital Volatility Masks Inefficiency

According to recent SEC filings, the company's cash conversion cycle has fluctuated significantly, reaching -30 days in 2026Q1, a metric that appears to be driven more by aggressive management of payables than by genuine operational efficiency or sustainable improvements in the underlying business model.

While a negative CCC can sometimes signal strong bargaining power, in this context, it likely reflects a desperate attempt to preserve liquidity by delaying payments to suppliers. The volatility in DSO and DIO suggests that the company's inventory and receivables management remains highly sensitive to shifting demand and subsidy cycles.

Liquidity Position Nearing Critical Threshold

Based on the latest quarterly filings, the company's current ratio has deteriorated to 0.32, a level that, as reported in financial statements, indicates a severe inability to cover short-term obligations with existing liquid assets, thereby heightening the risk of a near-term liquidity crisis for the firm.

The rapid decline from a current ratio of 7.38 in 2024Q2 highlights the exhaustion of the company's financial cushion. This precarious position warrants further investigation into the company's ability to secure additional funding, as current cash reserves appear insufficient to sustain ongoing operating losses.

Misapplication of SaaS Valuation Metrics

Investors frequently misapply traditional SaaS valuation multiples to SurgePays, ignoring that the company's financial profile, characterized by negative gross margins, more closely resembles a distressed telecommunications reseller than a high-margin software application provider, according to an analysis of recent industry-specific financial data.

Using P/S or growth-based multiples obscures the reality that the company's revenue is tied to low-margin, subsidy-dependent services rather than scalable software subscriptions. A more appropriate framework would focus on unit economics and cash burn rates, which better capture the structural risks inherent in the current business model.

Download Financial Ratios Data

Includes 30+ ratios · 19 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SURG — Frequently Asked Questions

Quick answers to the most common questions about buying SURG stock.

What is SurgePays, Inc.'s P/E ratio?

SurgePays, Inc.'s current P/E ratio is -0.2x. The historical average is 4.7x.

Is SURG stock overvalued?

Based on historical data, SurgePays, Inc. is trading at a P/E of -0.2x. Compare with industry peers and growth rates for a complete picture.

What are SurgePays, Inc.'s profit margins?

SurgePays, Inc. has -18.6% gross margin and -59.9% operating margin.